North America Point-of-Care Molecular Diagnostics Market
The North America Point-of-Care Molecular Diagnostics Market size was valued at US$ 860.9 Mn in 2021 and is projected to reach US$ 2,110.1 Mn by 2028, growing at a CAGR of 13.7% during 2021 - 2028.
Report Coverage
- Product & Services: Assays and Kits, Instruments, Services and Software
- Technology: PCR, Isothermal Nucleic Acid Amplification Technology, Other Technologies
- Application: Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications
- End User: Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes
US$ 860.9 Mn
Market size in 2021
US$ 2,110.1 Mn
Market Size by 2028
13.7%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Point-of-Care Molecular Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Point-of-Care Molecular Diagnostics Market Regional Analysis
6.2 North America Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America Point-of-Care Molecular Diagnostics Market Forecast Analysis
7. North America Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services
7.1 Assays and Kits
- 7.1.1 Overview
- 7.1.2 Assays and Kits: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Services and Software
- 7.3.1 Overview
- 7.3.2 Services and Software: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Point-of-Care Molecular Diagnostics Market Analysis – by Technology
8.1 PCR
- 8.1.1 Overview
- 8.1.2 PCR: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
- 8.2.1 Overview
- 8.2.2 Isothermal Nucleic Acid Amplification Technology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Other Technologies
- 8.3.1 Overview
- 8.3.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Point-of-Care Molecular Diagnostics Market Analysis – by Application
9.1 Infectious Diseases
- 9.1.1 Overview
- 9.1.2 Infectious Diseases: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Oncology
- 9.2.1 Overview
- 9.2.2 Oncology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Hematology
- 9.3.1 Overview
- 9.3.2 Hematology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Prenatal Testing
- 9.4.1 Overview
- 9.4.2 Prenatal Testing: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.5 Endocrinology
- 9.5.1 Overview
- 9.5.2 Endocrinology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.6 Other Applications
- 9.6.1 Overview
- 9.6.2 Other Applications: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Point-of-Care Molecular Diagnostics Market Analysis – by End User
10.1 Hospitals and Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals and Clinics: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Diagnostic Laboratories
- 10.2.1 Overview
- 10.2.2 Diagnostic Laboratories: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Research and Academic Institutes
- 10.3.1 Overview
- 10.3.2 Research and Academic Institutes: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. North America Point-of-Care Molecular Diagnostics Market – North America Analysis
11.1 Overview
11.2 North America- 11.2.1 North America Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 US: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.1.2 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.1.4 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.2 Canada: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.2.2 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.2.4 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.3 Mexico : North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
- 11.2.1.3.2 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
- 11.2.1.3.4 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 bioMérieux SA
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Danaher Corporation
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Enzo Biochem, Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Abbott
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 binx health, Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Meridian BioScience, Inc.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Biocartis
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Quidel Corporation
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Bio-Rad Laboratories, Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
